These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 37311212)

  • 1. Using Drosophila to identify naturally occurring genetic modifiers of amyloid beta 42- and tau-induced toxicity.
    Yang M; Zinkgraf M; Fitzgerald-Cook C; Harrison BR; Putzier A; Promislow DEL; Wang AM
    G3 (Bethesda); 2023 Aug; 13(9):. PubMed ID: 37311212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variation within endolysosomal system is associated with late-onset Alzheimer's disease.
    Gao S; Casey AE; Sargeant TJ; Mäkinen VP
    Brain; 2018 Sep; 141(9):2711-2720. PubMed ID: 30124770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide association study identifies four novel loci associated with Alzheimer's endophenotypes and disease modifiers.
    Deming Y; Li Z; Kapoor M; Harari O; Del-Aguila JL; Black K; Carrell D; Cai Y; Fernandez MV; Budde J; Ma S; Saef B; Howells B; Huang KL; Bertelsen S; Fagan AM; Holtzman DM; Morris JC; Kim S; Saykin AJ; De Jager PL; Albert M; Moghekar A; O'Brien R; Riemenschneider M; Petersen RC; Blennow K; Zetterberg H; Minthon L; Van Deerlin VM; Lee VM; Shaw LM; Trojanowski JQ; Schellenberg G; Haines JL; Mayeux R; Pericak-Vance MA; Farrer LA; Peskind ER; Li G; Di Narzo AF; ; ; Kauwe JS; Goate AM; Cruchaga C
    Acta Neuropathol; 2017 May; 133(5):839-856. PubMed ID: 28247064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide association reveals genetic effects on human Aβ42 and τ protein levels in cerebrospinal fluids: a case control study.
    Han MR; Schellenberg GD; Wang LS;
    BMC Neurol; 2010 Oct; 10():90. PubMed ID: 20932310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A data-driven study of Alzheimer's disease related amyloid and tau pathology progression.
    Aksman LM; Oxtoby NP; Scelsi MA; Wijeratne PA; Young AL; Alves IL; Collij LE; Vogel JW; Barkhof F; Alexander DC; Altmann A;
    Brain; 2023 Dec; 146(12):4935-4948. PubMed ID: 37433038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid, tau and risk of Alzheimer's disease: a Mendelian randomization study.
    Yeung CHC; Lau KWD; Au Yeung SL; Schooling CM
    Eur J Epidemiol; 2021 Jan; 36(1):81-88. PubMed ID: 32929646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular properties underlying regional vulnerability to Alzheimer's disease pathology.
    Grothe MJ; Sepulcre J; Gonzalez-Escamilla G; Jelistratova I; Schöll M; Hansson O; Teipel SJ;
    Brain; 2018 Sep; 141(9):2755-2771. PubMed ID: 30016411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma biomarkers and genetics in the diagnosis and prediction of Alzheimer's disease.
    Stevenson-Hoare J; Heslegrave A; Leonenko G; Fathalla D; Bellou E; Luckcuck L; Marshall R; Sims R; Morgan BP; Hardy J; de Strooper B; Williams J; Zetterberg H; Escott-Price V
    Brain; 2023 Feb; 146(2):690-699. PubMed ID: 35383826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide association study for variants that modulate relationships between cerebrospinal fluid amyloid-beta 42, tau, and p-tau levels.
    Maxwell TJ; Corcoran C; Del-Aguila JL; Budde JP; Deming Y; Cruchaga C; Goate AM; Kauwe JSK;
    Alzheimers Res Ther; 2018 Aug; 10(1):86. PubMed ID: 30153862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid-induced neurofibrillary tangle formation in Alzheimer's disease: insight from transgenic mouse and tissue-culture models.
    Götz J; Schild A; Hoerndli F; Pennanen L
    Int J Dev Neurosci; 2004 Nov; 22(7):453-65. PubMed ID: 15465275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ischemia-Reperfusion Programming of Alzheimer's Disease-Related Genes-A New Perspective on Brain Neurodegeneration after Cardiac Arrest.
    Pluta R; Czuczwar SJ
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
    Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
    Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BDNF Val66Met moderates memory impairment, hippocampal function and tau in preclinical autosomal dominant Alzheimer's disease.
    Lim YY; Hassenstab J; Cruchaga C; Goate A; Fagan AM; Benzinger TL; Maruff P; Snyder PJ; Masters CL; Allegri R; Chhatwal J; Farlow MR; Graff-Radford NR; Laske C; Levin J; McDade E; Ringman JM; Rossor M; Salloway S; Schofield PR; Holtzman DM; Morris JC; Bateman RJ;
    Brain; 2016 Oct; 139(Pt 10):2766-2777. PubMed ID: 27521573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Greater tau load and reduced cortical thickness in APOE ε4-negative Alzheimer's disease: a cohort study.
    Mattsson N; Ossenkoppele R; Smith R; Strandberg O; Ohlsson T; Jögi J; Palmqvist S; Stomrud E; Hansson O
    Alzheimers Res Ther; 2018 Aug; 10(1):77. PubMed ID: 30086796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic modifiers of tauopathy in Drosophila.
    Shulman JM; Feany MB
    Genetics; 2003 Nov; 165(3):1233-42. PubMed ID: 14668378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-Wide Epistasis Study of Cerebrospinal Fluid Hyperphosphorylated Tau in ADNI Cohort.
    Chen D; Li J; Liu H; Liu X; Zhang C; Luo H; Wei Y; Xi Y; Liang H; Zhang Q
    Genes (Basel); 2023 Jun; 14(7):. PubMed ID: 37510227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated biology approach reveals molecular and pathological interactions among Alzheimer's Aβ42, Tau, TREM2, and TYROBP in Drosophila models.
    Sekiya M; Wang M; Fujisaki N; Sakakibara Y; Quan X; Ehrlich ME; De Jager PL; Bennett DA; Schadt EE; Gandy S; Ando K; Zhang B; Iijima KM
    Genome Med; 2018 Mar; 10(1):26. PubMed ID: 29598827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tau load is associated with apolipoprotein E genotype and the amount of amyloid beta protein, Abeta40, in sporadic and familial Alzheimer's disease.
    Thaker U; McDonagh AM; Iwatsubo T; Lendon CL; Pickering-Brown SM; Mann DM
    Neuropathol Appl Neurobiol; 2003 Feb; 29(1):35-44. PubMed ID: 12581338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transgenic Drosophila models of Alzheimer's disease and tauopathies.
    Iijima-Ando K; Iijima K
    Brain Struct Funct; 2010 Mar; 214(2-3):245-62. PubMed ID: 19967412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tau PET in autosomal dominant Alzheimer's disease: relationship with cognition, dementia and other biomarkers.
    Gordon BA; Blazey TM; Christensen J; Dincer A; Flores S; Keefe S; Chen C; Su Y; McDade EM; Wang G; Li Y; Hassenstab J; Aschenbrenner A; Hornbeck R; Jack CR; Ances BM; Berman SB; Brosch JR; Galasko D; Gauthier S; Lah JJ; Masellis M; van Dyck CH; Mintun MA; Klein G; Ristic S; Cairns NJ; Marcus DS; Xiong C; Holtzman DM; Raichle ME; Morris JC; Bateman RJ; Benzinger TLS
    Brain; 2019 Apr; 142(4):1063-1076. PubMed ID: 30753379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.